Search results
This document discusses important areas of due diligence for companies considering partnering or acquiring another company's pharmaceutical or biologic products. It outlines key areas to examine including intellectual property, regulatory status of products, marketing applications, drug master files, preclinical and clinical research conducted, ...
12 Emerging Life Sciences Companies Deskbook The following is a detailed outline of various issues to consider when spinning out a new venture. Reasons for Spinning Out A. To free the Company from its parent’s resource allocation and planning decisions and other constraints that may not be consistent with its health and growth
50 Emerging Life Sciences Companies Deskbook Chapter 7 FREEDOM TO OPERATE As life sciences companies develop their patent portfolios, they come to realize that being able to patent their inventions is only the beginning. They must also be able to use their inventions to make and sell products.
Get Textbooks on Google Play. Rent and save from the world's largest eBookstore. Read, highlight, and take notes, across web, tablet, and phone.
Showing all editions for 'Emerging life sciences companies deskbook' Sort by: Format; All Formats (2) Print book (2) Refine Your Search; Year. 2008 (1) 2006 (1) Language. English; Displaying Editions 1 - 2 out of 2: Select All: Clear All: Save ... You can easily create a free account.
Advanced planning is critical for a life sciences company contemplating an initial public offering (IPO). With market forces narrowing available “windows” to go public, an issuer that is well-prepared shall be able to consummate an offering when the timing is right.
Life Sciences Emerging Markets Index: Poised for a new paradigm of growth. First-mover opportunities for life sciences companies and investors. At the beginning of 2021, JLL Research expanded its lens on life sciences to capture the qualities that define a new set of emerging life sciences markets.
